Cowell John K, Teng Yong, Bendzunas N George, Ara Roxan, Arbab Ali S, Kennedy Eileen J
Georgia Cancer Center, Augusta University, Augusta, GA, USA.
Department of Pharmaceutical & Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, GA, USA.
Cancer Growth Metastasis. 2017 Jun 19;10:1179064417713197. doi: 10.1177/1179064417713197. eCollection 2017.
The WASF3 gene facilitates the metastatic phenotype, and its inactivation leads to suppression of invasion and metastasis regardless of the genetic background of the cancer cell. This reliance on WASF3 to facilitate metastasis suggests that targeting its function could serve as an effective strategy to suppress metastasis. WASF3 stability and function are regulated by the WASF Regulatory Complex (WRC) of proteins, particularly CYFIP1 and NCKAP1. Knockdown of these proteins in vitro leads to disruption of the WRC and suppression of invasion. We have used mouse xenograft models of breast cancer metastasis to assess whether targeting the WRC complex suppresses metastasis in vivo. Stapled peptides targeting the WASF3-CYFIP1 interface (WAHM1) and the CYFIP1-NCKAP1 interface (WANT3) suppress the development of lung and liver metastases. Targeting these critical protein-protein interactions, therefore, could potentially be developed into a therapeutic strategy to control cancer cell invasion and metastasis.
WASF3基因促进转移表型,其失活导致侵袭和转移受到抑制,而与癌细胞的遗传背景无关。对WASF3促进转移的这种依赖性表明,靶向其功能可能是抑制转移的有效策略。WASF3的稳定性和功能由蛋白质的WASF调节复合物(WRC)调节,特别是CYFIP1和NCKAP1。在体外敲低这些蛋白质会导致WRC的破坏和侵袭的抑制。我们使用乳腺癌转移的小鼠异种移植模型来评估靶向WRC复合物是否在体内抑制转移。靶向WASF3-CYFIP1界面(WAHM1)和CYFIP1-NCKAP1界面(WANT3)的订书肽可抑制肺和肝转移的发展。因此,靶向这些关键的蛋白质-蛋白质相互作用可能会发展成为一种控制癌细胞侵袭和转移的治疗策略。